Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-16-098170

SVP & Chief Accounting Officer sold 15,000 shares at $11.49 ($172,350)

  • SVP & Chief Accounting Officer acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Thomsen Jillian B. · SVP & Chief Accounting Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-02-10 Exercise or conversion : show line 1 in the form +15,000 $6.65 $99,750 18,999 D
2016-02-10 Sale : show line 2 in the form −15,000 $11.49 $172,350 3,999 D
Open-market sales · 15,000 sh · avg $11.49 · $172,350

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-02-10 Exercise or conversion : show line 3 in the form Stock Option −15,000 $6.65 2016-03-19 15,000 15,000 D
Loading xslF345X03/doc4.xml…